𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acidic glycosphingolipids of cock testis elucidated by mass spectrometry and NMR spectroscopy

✍ Scribed by Dumitru-Petru Iga; Silvia Iga; Thomas Larsson; Jonas Ångström; Bassam Soussi; Olivier Rakotonirainy; Halina Miller-Podraza

Book ID
110244408
Publisher
Springer US
Year
1998
Tongue
English
Weight
64 KB
Volume
15
Category
Article
ISSN
1573-4986

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study of Lysozyme Glycation Reaction by
Study of Lysozyme Glycation Reaction by Mass Spectrometry and NMR Spectroscopy
✍ Yukiko Maekawa; Makiko Sugiura; Atsuko Takeuchi; Koji Tomoo; Toshimasa Ishida; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 German ⚖ 175 KB

## Abstract The Advanced Glycation End Products (AGEs) are the causative substances of lifestyle‐habit illness. To elucidate the glycation mechanism of the protein, the reaction of lysozyme with D‐glucose was analyzed by the fluorescence, TOF‐MS, and ^13^C‐NMR spectroscopy under the physiological c

Lipopolysaccharide core region of Hafnia
Lipopolysaccharide core region of Hafnia alvei: structure elucidation using chemical methods, gas chromatography-mass spectrometry, and NMR spectroscopy
✍ Andrzej Gamian; Ewa Katzenellenbogen; Elzbieta Romanowska; Ursula Dabrowski; Jan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 638 KB

Sugar and methylation analysis with the use of gas chromatography+mass spectrometry and lit NMR spectroscopy proved that the core oligosaccharides isolated from lipopolysaccharides of eight Hajhia alvei strains have the identical hexasaccharide skeleton. However, tH,3tP heterocorrelatcd spectra show

Structural elucidation of two major meta
Structural elucidation of two major metabolites of crisnatol in the rat by NMR and mass spectrometry
✍ John P. Shockcor; Dipak K. Patel; Robert L. Johnson; Lester C. E. Taylor; Pisal 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

## Abstract NMR and mass spectral data are presented in support of the structures of two metabolites of crisnatol, 2‐[(6‐chrysenylmethyl)amino]‐2‐methylpropane‐1,3‐diol, a novel DNA intercalator currently undergoing Phase II clinical trials as an anticancer agent. Elucidation of the structures of t